Michelle Swanson-Mungerson is
a Professor at the Department of Microbiology and Immunology, College of
Graduate Studies, Midwestern University. She earned her Ph.D. in Immunology
from Loyola University Stritch School of Medicine in 2002, followed by a
post-doctoral fellowship at the Feinberg School of Medicine at Northwestern
University until 2008. She then became a faculty member at Midwestern University,
where she teaches immunology and infectious disease in multiple programs. She
is a National Faculty Member for the NBOME and contributes to the COMLEX and
the Foundations of Biomedical Sciences COMAT. She is a member of the American
Association of Immunology and serves on their Education Committee. One of the long-term
goals of her laboratory is to understand how EBV influences the tumor
microenvironment in HL in order to develop novel strategies to enhance HL
treatment success. Current projects in her lab are addressing two critical
areas to investigate how LMP2A directly promotes the generation of a tumor
microenvironment that promotes tumor survival and inhibits the anti-tumor
immune response. Another long-term goal is to understand the mechanisms by
which cyanobacteria LPS activate cells of the immune system to promote disease.
Michelle Swanson-Mungerson is
a Professor at the Department of Microbiology and Immunology, College of
Graduate Studies, Midwestern University. She earned her Ph.D. in Immunology
from Loyola University Stritch School of Medicine in 2002, followed by a
post-doctoral fellowship at the Feinberg School of Medicine at Northwestern
University until 2008. She then became a faculty member at Midwestern University,
where she teaches immunology and infectious disease in multiple programs. She
is a National Faculty Member for the NBOME and contributes to the COMLEX and
the Foundations of Biomedical Sciences COMAT. She is a member of the American
Association of Immunology and serves on their Education Committee. One of the long-term
goals of her laboratory is to understand how EBV influences the tumor
microenvironment in HL in order to develop novel strategies to enhance HL
treatment success. Current projects in her lab are addressing two critical
areas to investigate how LMP2A directly promotes the generation of a tumor
microenvironment that promotes tumor survival and inhibits the anti-tumor
immune response. Another long-term goal is to understand the mechanisms by
which cyanobacteria LPS activate cells of the immune system to promote disease.